Wolverine Trading, LLC Galectin Therapeutics Inc Call Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Call Options

18 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	BUY	$1.6 - $2.44 $17,440 - $26,596	10,900 New	10,900 $26,000
Q3 2022 Nov 14, 2022	BUY	$1.31 - $2.48 $7,205 - $13,640	5,500 Added 48.25%	16,900 $28,000
Q2 2022 Aug 15, 2022	BUY	$1.19 - $1.74 $1,666 - $2,436	1,400 Added 14.0%	11,400 $14,000
Q1 2022 May 16, 2022	BUY	$1.61 - $2.31 $16,100 - $23,100	10,000 New	10,000 $17,000
Q3 2021 Nov 12, 2021	SELL	$2.59 - $4.15 $53,095 - $85,075	-20,500 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$2.07 - $5.1 $20,286 - $49,980	9,800 Added 91.59%	20,500 $71,000
Q1 2021 May 14, 2021	SELL	$1.96 - $2.57 $10,976 - $14,392	-5,600 Reduced 34.36%	10,700 $22,000
Q4 2020 Feb 12, 2021	BUY	$2.24 - $2.87 $7,392 - $9,471	3,300 Added 25.38%	16,300 $37,000
Q3 2020 Nov 13, 2020	SELL	$2.53 - $3.64 $23,276 - $33,488	-9,200 Reduced 41.44%	13,000 $43,000
Q1 2020 May 11, 2020	BUY	$1.51 - $3.0 $18,422 - $36,600	12,200 Added 122.0%	22,200 $44,000
Q3 2019 Nov 14, 2019	SELL	$3.0 - $4.05 $11,700 - $15,795	-3,900 Reduced 28.06%	10,000 $36,000
Q2 2019 Aug 20, 2019	SELL	$3.61 - $5.0 $23,104 - $32,000	-6,400 Reduced 31.53%	13,900 $58,000
Q1 2019 May 15, 2019	BUY	$3.86 - $6.02 $26,248 - $40,936	6,800 Added 50.37%	20,300 $104,000
Q4 2018 Feb 14, 2019	SELL	$3.43 - $5.74 $71,687 - $119,966	-20,900 Reduced 60.76%	13,500 $51,000
Q3 2018 Nov 14, 2018	SELL	$3.68 - $6.93 $6,624 - $12,474	-1,800 Reduced 4.97%	34,400 $207,000
Q1 2018 May 15, 2018	BUY	$3.78 - $5.97 $136,836 - $216,114	36,200 New	36,200 $172,000
Q4 2017 Feb 14, 2018	SELL	$1.54 - $3.34 $96,712 - $209,752	-62,800 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$1.67 - $2.3 $104,876 - $144,440	62,800	62,800 $134,000

Others Institutions Holding GALT

# of Institutions

Shares Held

9.65M

Call Options Held

1.16M

Put Options Held

1.98M

Vanguard Group Inc Valley Forge, PA

2.13M
Shares

$4.42 Million
0.0% of portfolio
Black Rock Inc. New York, NY

1.56M
Shares

$3.24 Million
0.0% of portfolio
Advisor Group Holdings, Inc. Phoenix, AZ

1.18M
Shares

$2.45 Million
0.01% of portfolio
Geode Capital Management, LLC Boston, MA

863K
Shares

$1.79 Million
0.0% of portfolio
Commonwealth Equity Services, LLC

483K
Shares

$1 Million
0.0% of portfolio

View Full List

About GALECTIN THERAPEUTICS INC

Ticker GALT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,426,000
Market Cap $123M
Description
Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial f...

More about GALT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account